| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ocugen, Inc. (OCGN) has 4 insiders with recent SEC Form 4 filings, including 4 buys and 0 sells. OCGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 4.96M | $6.15M | - | |
| Dir | 1.29M | $1.60M | - | |
| CFO | 521.0K | $646.0K | - | |
| Other | 310.9K | $385.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2016 | Gill David N | Director | Buy | 5,000 | $1.92 | $9,600.00 | New | |
| Dec 2, 2016 | Lieber Jonathan I | Chief Financial Officer | Buy | 5,000 | $1.95 | $9,730.50 | New | |
| Dec 1, 2016 | Gridley Adam | President And CEO | Buy | 5,000 | $2.01 | $10,039.50 | New | |
| Sep 29, 2016 | Split Rock Partners Ii, LP | 10% Owner | Buy | 276,801 | $2.25 | $622,802.25 | +20.0% |